Ræder
Ræder's Syndrome is a rare neurological disorder characterized by a constellation of symptoms primarily affecting the head and facial region. It is also known as Paratrigeminal Parasympathetic Syndrome. The syndrome is named after Norwegian neurologist Johan Georg Ræder, who first described the condition in the early 20th century.
Symptoms and Signs[edit]
Ræder's Syndrome is marked by a combination of symptoms, including:
- Unilateral headache, often described as severe and throbbing
- Ptosis (drooping of the upper eyelid)
- Miosis (constriction of the pupil)
- Anhidrosis (absence of sweating) on the affected side of the face
- Occasionally, Facial pain in the distribution of the trigeminal nerve
These symptoms are attributed to the involvement of the parasympathetic fibers located around the trigeminal nerve, leading to a disruption in autonomic functions in the head and face.
Causes[edit]
The exact cause of Ræder's Syndrome remains unclear. However, it is believed to be associated with lesions or abnormalities affecting the sympathetic pathways near the trigeminal nerve. These abnormalities may include:
- Tumors, particularly those located at the base of the brain or in the pituitary gland
- Inflammation or infection affecting the cranial nerves
- Traumatic injuries to the head or face
- Vascular anomalies
Diagnosis[edit]
Diagnosis of Ræder's Syndrome involves a thorough clinical evaluation, including a detailed patient history and physical examination. Diagnostic tests may include:
- Magnetic Resonance Imaging (MRI) to identify any structural abnormalities
- Computed Tomography (CT) Scan for detailed imaging of the cranial region
- Blood tests to rule out inflammatory or infectious conditions
Treatment[edit]
Treatment of Ræder's Syndrome is primarily focused on managing symptoms and addressing the underlying cause, if identified. Options may include:
- Pain management with medications such as analgesics or nerve block injections
- Treatment of any identified tumors or lesions through surgery or radiation therapy
- Management of inflammation or infection with appropriate medications
Prognosis[edit]
The prognosis for individuals with Ræder's Syndrome varies depending on the underlying cause and the effectiveness of treatment. In cases where a treatable cause is identified and successfully managed, symptoms may improve significantly or resolve completely.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
